文献速递乳腺癌放疗胸部肿瘤放疗

乳腺癌放疗后炎症标志物与放射性肺损伤、转移及死亡率的关系

Inflammatory Markers Associated With Radiation-Induced Lung Injury, Metastasis and Mortality After Breast Cancer Treatment.
PubMed 文献 · Adv Radiat Oncol · 2025-08-28

该前瞻性纵向队列研究纳入术后乳腺癌放疗患者,在放疗前及放疗后3、6、12个月和长期随访7-12年时检测炎症标志物,并登记至放疗后16年的转移与总生存。结果显示3个月时单核细胞趋化蛋白1可预测12个月临床放射性肺纤维化,基线及基线至3个月变化的多种标志物与转移相关,部分标志物与全因死亡率相关。

要点

  • 3个月时单核细胞趋化蛋白1预测12个月临床放射性肺纤维化。
  • 基线TNF-α及基线至3个月bFGF、NLR、CRP、IL-1b变化预测乳腺癌转移。
  • 3和12个月IL-6、12个月IL-8及bFGF和IL-6升高与全因死亡率相关。

核心结论

  • 单核细胞趋化蛋白1与放射性肺损伤相关,放疗前后炎症标志物与乳腺癌转移和全因死亡率相关。
  • 放疗后持续炎症可能与乳腺癌转移和总生存相关,但需进一步研究其信号通路及预测作用。

研究设计与样本

  • 前瞻性纵向队列研究,纳入术后接受乳腺癌放疗的患者,放疗前及放疗后3、6、12个月和长期随访7至12年时评估炎症标志物,并登记至放疗后16年的转移与总生存。

主要发现

  • 3个月时单核细胞趋化蛋白1是12个月临床放射性肺纤维化的预测因子。
  • 基线肿瘤坏死因子α及基线至3个月碱性成纤维细胞生长因子、中性粒细胞淋巴细胞比值、C反应蛋白和白细胞介素1b的变化预测乳腺癌转移。
  • 3和12个月白细胞介素6、12个月白细胞介素8及基线至3个月碱性成纤维细胞生长因子和白细胞介素6升高与全因死亡率相关。

临床怎么用

  • 可关注放疗前及放疗后3个月炎症标志物动态变化,辅助识别放射性肺纤维化、转移及死亡高风险患者。

局限性

  • 炎症标志物预测乳腺癌结局的信号通路和作用尚不明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Breast cancer (BC) radiation therapy (RT) prevents local recurrence and improves survival. However, it can induce acute and late effects on organs at risk, such as the lung. In some patients, radiation activates inflammatory markers, which promote inflammation in the lung leading to radiation pneumonitis and fibrosis (RF). Moreover, inflammatory markers may be associated with metastatic disease and survival. This study examines the relationships between inflammatory markers and clinical radiation pneumonitis and RF and explores their potential to predict BC metastasis or overall survival. METHODS AND MATERIALS: Patients prescribed postoperative BC RT were included in this prospective longitudinal cohort study with assessments before RT (baseline) and after 3, 6, and 12 months and at a long-term follow-up 7 to 12 years after RT. Inflammatory markers from each assessment were analyzed. BC metastasis and overall survival were registered up to 16 years after RT. RESULTS: Monocyte chemoattractant protein 1 at 3 months emerged as a predictor for clinical RF at 12 months. Tumor necrosis factor alpha at baseline and the change in fibroblast growth factor basic, neutrophil lymphocyte ratio, C-reactive protein, and interleukin (IL) 1b (IL-1b) from baseline to 3 months predicted BC metastasis. IL-6 at 3 and 12 months, IL-8 at 12 months, and an increase in fibroblast growth factor basic and IL-6 from baseline to 3 months were associated with all-cause mortality. CONCLUSIONS: We found monocyte chemoattractant protein 1 linked to radiation-induced lung injury. Inflammatory markers before and after RT were associated with BC metastasis and all-cause mortality. Our findings indicate that prolonged inflammation following RT may be linked with BC metastasis and overall survival. However, further research is needed to understand their signaling pathways and their role in predicting BC outcomes.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Karlsen J, Giskeødegård G, Tandstad T, et al. Inflammatory Markers Associated With Radiation-Induced Lung Injury, Metastasis and Mortality After Breast Cancer Treatment. Adv Radiat Oncol. 2025. PMID: 41333180. doi:10.1016/j.adro.2025.101894

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。